MRNS - MARINUS PHARMACEUTICALS, INC.
IEX Last Trade
0.3625
-0.003 -0.745%
Share volume: 10,188
Last Updated: Fri 27 Dec 2024 08:27:55 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.37
0.00
-0.74%
Summary score
32%
Profitability
25%
Dept financing
30%
Liquidity
75%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-72.07%
Return on assets
-17.38%
Return on sales
-1407.56%
Return on invested capital
140.39%
Total debt ratio
54.25%
Debt ratio change over timeo
-0.67%
Current Ratio
7.43%
Quick Ratio
7.14%
Cash Position Ratio
6.92%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.5%
Return on assets
-19.55%
Return on sales
-476.9%
Return on invested capital
131.46%
Total debt ratio
86.62%
Debt ratio change over timeo
-0.36%
Current Ratio
5.28%
Quick Ratio
5.18%
Cash Position Ratio
4.74%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
235.3%
Return on assets
-26.08%
Return on sales
-466.48%
Return on invested capital
105.41%
Total debt ratio
111.97%
Debt ratio change over time
-0.06%
Current Ratio
3.07%
Quick Ratio
2.93%
Cash Position Ratio
2.65%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.02%
Return on assets
-110.26%
Return on sales
-790.96%
Return on invested capital
-28.53%
Total debt ratio
-67.38%
Debt ratio change over time
-0.67%
Current Ratio
3.15%
Quick Ratio
3.24%
Cash Position Ratio
2.86%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRNS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -72.07% | 18.83% | 17.34% | 7.6% |
| Return on assets | -17.38% | 4.16% | 8.21% | 3.22% |
| Return on sales | -1407.56% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 140.39% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 57% | 73% | 37% |
| Total debt ratio | 54.25% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -0.67% | -4.38% | -0.73% | -33.74% |
| Dept financing | 41% | 25% | 17% | 18% |
| Current Ratio | 5.28% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.18% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.74% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 8% | 10% |
| Short-term ratios | MRNS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -32.5% | 13.31% | 0% | 13.48% |
| Return on assets | -19.55% | 4.72% | 0% | 3.05% |
| Return on sales | -476.9% | 31.4% | 0% | 25.56% |
| Return on invested capital | 131.46% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 77% | 0% | 64% |
| Total debt ratio | 86.62% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -0.36% | -41.82% | 0% | 7.13% |
| Dept financing | 25% | 23% | 0% | 42% |
| Current Ratio | 5.28% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.18% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.74% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 10% | 0% | 13% |